-
公开(公告)号:US20240010615A1
公开(公告)日:2024-01-11
申请号:US18253137
申请日:2021-12-20
发明人: Yuto YABUUCHI , Yuki TAKEUCHI
IPC分类号: C07C405/00
CPC分类号: C07C405/00 , C07B2200/09 , C07C2601/08
摘要: The present invention provides a method for separating a compound represented by Formula (1) or (2) [in the formula, P1 is a hydrogen atom or a protective group of a hydroxyl group, R1 is a linear or branched C1-6 alkyl group that may be substituted with a phenyl group, A is an alkenylene group, and R2 is a hydroxyl group, a C1-3 alkoxy group, a mono(C1-3 alkyl)amino group, or a di(C1-3 alkyl)amino group] from a geometrical isomer thereof, in which the geometrical isomer is a geometrical isomer in a double bond included in A, the method including processing a mixture containing the compound and the geometrical isomer thereof by a chromatographic method using an acidic functional group-modified silica gel as a stationary phase.
-
公开(公告)号:US09856213B2
公开(公告)日:2018-01-02
申请号:US14965515
申请日:2015-12-10
申请人: CHINOIN ZRT
发明人: Gábor Havasi , Tibor Kiss , Irén Hortobágyi , Zsuzsanna Kardos , István Lászlófi , Zoltán Bischof , Ádám Bódis
IPC分类号: C07C405/00 , C07D207/46 , C07D209/48 , C07D233/60 , C07D307/935 , C07D209/50
CPC分类号: C07C405/0041 , C07B2200/13 , C07C405/00 , C07C2601/08 , C07D207/46 , C07D209/48 , C07D209/50 , C07D233/60 , C07D307/935
摘要: The subject of the invention is process for the preparation of the prostaglandin amides of the general formula I, where in the formula the bonds marked with dotted lines may be single or double bonds, in the case of double bounds at positions 5,6 and 13,14 they may be in cis or in trans orientation, Q stands for a hydroxyl-group and Z stands for a hydroxyl- or oxo-group, R1 and R2 independently represent hydrogen atom or a straight or branched C1-10 alkyl- or aralkyl-group, optionally substituted with —ONO2 group, or an aralkyl- or aryl-group, which contains heteroatom, R3 represents a straight or branched, saturated or unsaturated C4-6 hydrocarbon group, or a C4-10 alkylcycloalkyl- or cycloalkyl-group, or an optionally with alkyl group or halogen atom substituted phenyl-, C7-10 alkylaryl- or hetaryl-group, Y represents (CH2)n group or O atom or S atom, and where n=0-3.
-
公开(公告)号:US09828356B2
公开(公告)日:2017-11-28
申请号:US14802026
申请日:2015-07-17
发明人: Shih-Yi Wei , Yu-Chih Yeh , Min-Kuan Hsu , Li-Ta Kao
IPC分类号: C07D313/00 , C07C69/618 , C07C69/608 , C07F7/18 , C07D309/12 , C07C51/347 , C07D407/12 , C07D405/00 , C07C67/10 , C07C59/72 , C07C405/00 , C07C231/02 , C07D407/14
CPC分类号: C07D313/00 , C07C51/347 , C07C59/72 , C07C67/10 , C07C69/608 , C07C69/618 , C07C231/02 , C07C405/00 , C07C405/0016 , C07C405/0041 , C07C2601/08 , C07D309/12 , C07D407/12 , C07D407/14 , C07F7/1804 , C07F7/1864
摘要: Novel processes for the preparation of a compound of Formula I-2 substantially free of the 5,6-trans isomer: wherein R2, R3 and R4 are as defined in the specification are provided. Novel intermediates for the preparations of isomer free Prostaglandins and derivatives thereof are also provided.
-
公开(公告)号:US09382272B2
公开(公告)日:2016-07-05
申请号:US13145999
申请日:2010-01-22
申请人: Kiran Kumar Kothakonda , Fan Wang , Bhaskar Reddy Guntoori , Minh T. N. Nguyen , Alfredo Paul Ceccarelli , Yajun Zhao , Uma Kotipalli , Sammy Chris Duncan , Kaarina K. Milnes , Kevin Wade Kells , Laura Kaye Montemayor
发明人: Kiran Kumar Kothakonda , Fan Wang , Bhaskar Reddy Guntoori , Minh T. N. Nguyen , Alfredo Paul Ceccarelli , Yajun Zhao , Uma Kotipalli , Sammy Chris Duncan , Kaarina K. Milnes , Kevin Wade Kells , Laura Kaye Montemayor
IPC分类号: C07D323/04 , C07D311/00 , C07D315/00 , C07D307/93 , C07C61/06 , C07C69/74 , C07F7/18 , C07C69/734 , C07C69/738 , C07C405/00 , C07D307/935
CPC分类号: C07F7/1892 , C07C69/734 , C07C69/738 , C07C405/00 , C07C2601/08 , C07D307/935
摘要: There is provided processes for preparing Lubiprostone and intermediates thereof. Also provided are compounds, including intermediates for preparing Lubiprostone as well compositions comprising Lubiprostone and other compounds, including intermediates for preparing Lubiprostone and other compounds. (I)
摘要翻译: 提供了用于制备卢比克石及其中间体的方法。 还提供了化合物,包括用于制备柳替罗石的中间体以及包含卢比石和其它化合物的组合物,包括用于制备柳普罗石和其它化合物的中间体。 (一世)
-
公开(公告)号:US09353055B2
公开(公告)日:2016-05-31
申请号:US14594668
申请日:2015-01-12
发明人: Robert R. Hogan , Ronald Rossi
IPC分类号: C07C69/74 , C07C405/00 , C07D307/93 , C07D307/937 , C07C69/732 , C07C323/56
CPC分类号: C07C405/00 , C07C69/732 , C07C323/56 , C07C2601/08 , C07C2603/14 , C07D307/93 , C07D307/937 , Y02P20/544
摘要: The present invention provides a method for the purification of a prostaglandin by supercritical fluid chromatography, said method comprising the use of a stationary phase and a mobile phase comprising carbon dioxide, provided that when the stationary phase is unmodified silica gel, the prostaglandin is not luprostiol. The invention also provides prostaglandins obtainable by the method.
-
公开(公告)号:US20160137602A1
公开(公告)日:2016-05-19
申请号:US14965489
申请日:2015-12-10
申请人: CHINOIN ZRT
发明人: Gábor HAVASI , Tibor KISS , Irén HORTOBÁGYI , Zsuzsanna KARDOS , István LÁSZLÓFI , Zoltán BISCHOF , Ádám BÓDIS
IPC分类号: C07D209/50 , C07C405/00 , C07D207/46
CPC分类号: C07C405/0041 , C07B2200/13 , C07C405/00 , C07C2601/08 , C07D207/46 , C07D209/48 , C07D209/50 , C07D233/60 , C07D307/935
摘要: The subject of the invention is process for the preparation of the prostaglandin amides of the general formula I, where in the formula, the bonds marked with dotted lines may be single or double bonds, in the case of double bounds at positions 5, 6 and 13, 14 they may be in cis or in trans orientation, Q stands for a hydroxyl-group and Z stands for a hydroxyl- or oxo-group, R1 and R2 independently represent hydrogen atom or a straight or branched C1-10 alkyl- or aralkyl-group, optionally substituted with —ONO2 group, or an aralkyl- or aryl-group, which contains heteroatom, R3 represents a straight or branched, saturated or unsaturated C4-6 hydrocarbon group, or a C4-10 alkylcycloalkyl- or cycloalkyl-group, or an optionally with alkyl group or halogen atom substituted phenyl-, C7-10 alkylaryl- or hetaryl-group, Y represents (CH2)n group or O atom or S atom, and where n=0-3.
摘要翻译: 本发明的主题是制备通式I的前列腺素酰胺的方法,其中在该式中,用虚线标记的键可以是单键或双键,在5,6位的双重界限的情况下, 13,14可以是顺式或反向取代,Q表示羟基,Z表示羟基或氧代基,R1和R2独立地表示氢原子或直链或支链C1-10烷基或 任选被-ONO 2基团取代的芳烷基,或含有杂原子的芳烷基 - 或芳基,R 3表示直链或支链,饱和或不饱和的C 4-6烃基或C 4-10烷基环烷基 - 或环烷基 - 基团或任选具有烷基或卤素原子取代的苯基 - ,C7-10烷基芳基或杂芳基,Y表示(CH 2)n基团或O原子或S原子,并且其中n = 0-3。
-
公开(公告)号:US09012662B2
公开(公告)日:2015-04-21
申请号:US14464922
申请日:2014-08-21
发明人: Julian Paul Henschke , Yuanlian Liu , Lizhen Xia , Yung-Fa Chen
IPC分类号: C07C69/716 , C07C59/215 , C07C29/143 , C07C33/42 , C07C405/00 , C07D311/94 , C12P31/00 , C07D311/74
CPC分类号: C07C69/716 , C07C29/143 , C07C33/42 , C07C59/215 , C07C405/00 , C07C2601/08 , C07D311/74 , C07D311/94 , C12P31/00 , C12Y301/01003
摘要: Intermediates of the following formulae for the preparation of lubiprostone:
摘要翻译: 下列配方的中间体用于制备罗哌磷:
-
公开(公告)号:US08957240B2
公开(公告)日:2015-02-17
申请号:US13953236
申请日:2013-07-29
发明人: Robert R. Hogan , Ronald Rossi
IPC分类号: C07C61/06 , C07C69/76 , C07C69/74 , C07C233/00 , C07C69/732 , C07C405/00 , C07D307/93 , C07D307/937 , C07C323/56
CPC分类号: C07C405/00 , C07C69/732 , C07C323/56 , C07C2601/08 , C07C2603/14 , C07D307/93 , C07D307/937 , Y02P20/544
摘要: The present invention provides a method for the purification of a prostaglandin by supercritical fluid chromatography, said method comprising the use of a stationary phase and a mobile phase comprising carbon dioxide, provided that when the stationary phase is unmodified silica gel, the prostaglandin is not luprostiol. The invention also provides prostaglandins obtainable by the method.
摘要翻译: 本发明提供了一种通过超临界流体色谱法纯化前列腺素的方法,所述方法包括使用固定相和包含二氧化碳的流动相,条件是当固定相为未改性硅胶时,前列腺素不是芦丁醇 。 本发明还提供可通过该方法获得的前列腺素。
-
公开(公告)号:US20150005528A1
公开(公告)日:2015-01-01
申请号:US14464922
申请日:2014-08-21
发明人: Julian Paul HENSCHKE , Yuanlian LIU , Lizhen XIA , Yung-Fa CHEN
IPC分类号: C07C69/716 , C07C59/215
CPC分类号: C07C69/716 , C07C29/143 , C07C33/42 , C07C59/215 , C07C405/00 , C07C2601/08 , C07D311/74 , C07D311/94 , C12P31/00 , C12Y301/01003
摘要: Intermediates of the following formulae for the preparation of lubiprostone:
摘要翻译: 下列配方的中间体用于制备罗哌磷:
-
公开(公告)号:US20140120058A1
公开(公告)日:2014-05-01
申请号:US14111408
申请日:2012-04-12
申请人: Michael Shane O'Shea , Florian Hans Maximillian Graichen , Russell John Tait , Andrew Craig Donohue , Sarah Man Yee Ng , Asha Marina D'Souza
发明人: Michael Shane O'Shea , Florian Hans Maximillian Graichen , Russell John Tait , Andrew Craig Donohue , Sarah Man Yee Ng , Asha Marina D'Souza
IPC分类号: A61K47/48
CPC分类号: A61K47/595 , C07C405/00
摘要: The present invention relates in general to polymer-drug conjugates. In particular, the invention relates to polymer-drug conjugates wherein the conjugated drugs are selected from prostaglandins and substituted prostaglandins, to a method of delivering such prostaglandin drugs to a subject, to a sustained drug delivery system comprising the polymer-drug conjugates, to a method of preparing the polymer-drug conjugates, and to an implant comprising the polymer-drug conjugates. The polymer-drug conjugates may be useful for delivering prostaglandins and substituted prostaglandins for the treatment of glaucoma.
摘要翻译: 本发明一般涉及聚合物 - 药物共轭物。 特别地,本发明涉及其中所述共轭药物选自前列腺素和取代的前列腺素的聚合物 - 药物偶联物,涉及将这种前列腺素药物递送至受试者的方法,包括所述聚合物 - 药物共轭物的持续药物递送系统, 制备聚合物 - 药物共轭物的方法,以及包含聚合物 - 药物共轭物的植入物。 聚合物 - 药物共轭物可用于递送前列腺素和替代的前列腺素用于治疗青光眼。
-
-
-
-
-
-
-
-
-